uniQure基因治疗

最新新闻

• 评级变动
  Barclays Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $65
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• 评级变动
  Analysts' Top Healthcare Picks: UniQure (QURE), Alumis Inc. (ALMS)
  TipRanks · 2026/9/3
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)
  TipRanks · 2026/7/30
• Barclays Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/10/6
• Barclays Downgrades UniQure NV(QURE.US) to Hold Rating, Cuts Target Price to $28
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• Stifel Maintains UniQure NV(QURE.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• 评级变动
  H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $80
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $80
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  William Blair Upgrades UniQure NV(QURE.US) to Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Analysts Are Bullish on These Healthcare Stocks: UniQure (QURE), Biohaven Ltd. (BHVN)
  TipRanks · 2026/6/18
• 评级变动
  A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $46 to $68
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $75
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 评级变动
  Mizuho Securities Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $68
  \u5e02\u573a\u8d44\u8baf · 2026/6/25
• 评级变动
  Goldman Sachs Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $46
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $46 to $70
  \u5e02\u573a\u8d44\u8baf · 2026/6/18
• RBC Capital Maintains UniQure NV(QURE.US) With Buy Rating, Cuts Target Price to $48
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $71
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $31 to $80
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $71
  \u5e02\u573a\u8d44\u8baf · 2026/6/22
• 评级变动
  TD Cowen Maintains UniQure NV(QURE.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/3
• 评级变动
  RBC Capital Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/5/7

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。